SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MILLENNIUM LIMITED (MHD)

Delisted from ASX 14/08/2020

SHARE PRICES

(updated at weekends)
2017 2018 2020   ALL

Former (or subsequent) names

Shareholder links

 

REGISTRY:
Computershare, Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000MHD7
Address: Suite 145, Regis Tower, 416-418 Pitt Street, Sydney, NSW, AUSTRALIA, 2000
Tel:  (02) 92124881 Fax: (02) 83246353

Date first listed: 20/03/2009
Company Secretary: Ying Huang
Sector: Consumer Durables & Apparel
Industry Group: XDJ
Activities: Supply and marketing of high-end fabrics, home textiles and luxury fashion decor globally
OFX Transferring Money Internationally to Free

delisted from the commencement of trading on Friday, 14 August 2020, pursuant to Listing rule 17.12.

14/08/2020

we understand this company failed and ASX removed the company from listing because its securities have been suspended from trading for a period of two years

14/08/2020

Shareholders in this company should consider crystallising a capital loss in 2020/21 by selling their worthless shares, which they can achieve online by entering transaction details here. While this usually makes good economic sense, we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.

13/08/2020

The company has withdrawn the offer under the replacement prospectus for its proposed acquisition of Advent Health. ASX has advised to revoke the extension of removal date provided on 23 July 2020 given MHD is no longer in the final stage of implementing a transaction that will lead to the resumption of trading in its securities. ASX will remove MHD from the official list of ASX from the open of trading on 14 August 2020.

03/08/2020

The company has withdrawn the offer under the replacement prospectus dated 18 May 2020. While there has been considerable interest in Advent Health during the offer period from private and institutional investors, Advent Health will be considering alternative capital raising strategies including from private equity firms.

31/07/2020

The company lodges an Appendix 4C - quarterly.

27/07/2020

The company sought an extension of its removal date from ASX to allow the company further time to complete its proposed acquisition, capital raising and recompliance with Chapter 1 and 2 of the Listing Rules. ASX has granted an extension to MHD's removal date from 13 August 2020 to 13 November 2020. ASX has further advised that this is a one-off extension and no further extension will be provided beyond 13 November 2020. MHD must demonstrate compliance with Chapter 1 and 2 of the Listing Rules by that date, in the event that MHD has not satisfied the readmission criteria by 13 November 2020, it will be removed from the Official List on 14 November 2020.

24/07/2020

The Board has resolved to extend the closing date of the public offer. The offer will now close on 31 July 2020 at 5pm, subject to the right of the company to close the public offer early or further extend the closing date.

26/06/2020

The company has lodged a replacement prospectus with Australian Securities and Investments Commission on 18 May 2020. This is in response to the interim stop order issued by ASIC on the prospectus dated 13 March 2020 which has now been removed by ASIC. Forecasts for FY20 and FY21 have been removed at the request of ASIC as they could be subject to such a broad range of potential outcomes, making them confusing and potentially misleading. An analysis of trends since the start of the lockdowns give the Directors reason to be cautiously optimistic that historic profitability levels of the group overall will be restored in the coming months. An analysis of the weekly revenue figures for the group from the middle of March to the first week in May show the weekly aggregated revenues declined up to a peak of approximately 30% in midApril (or 20% if seasonally adjusted for Easter) and are now running at an approximately 10 to 15% below trend but on an upward trajectory. The majority of practice groups anticipate returning to pre-COVID-19 revenues or single digit revenue reductions in the next four to six weeks.

21/05/2020

The company lodges its Appendix 4C - quarterly.

21/04/2020

The company releases a disclosure document. Allied health services remain an "essential" service and are therefore continuing. Allied health services promote health and consequently patients require less visits to the General Practitioner and other emergency in-demand services. The Advent Health group is well positioned to respond to the current COVID-19 conditions. The Directors believe it is prudent to assess the impact of the COVID-19 pandemic on the group businesses including the FY21 forecast in the prospectus. Due to the level of uncertainty resulting from the COVID-19 pandemic, on 2 April 2020, ASIC issued an interim stop order in relation to the Prospectus. No offers, issues, sales or transfers of shares can be made under the Prospectus while the interim stop order is in force. The Company expects to lodge a Replacement Prospectus addressing the concerns raised by ASIC.

06/04/2020

The company releases the typeset version of the prospectus to replace the word version lodged on 13 Marhc 2020. The typeset version of the prospectus corrected a number of graphic tables which were not properly shown. It includes images and illustrations, and the contents has no material changes.

18/03/2020

The Company issues a prospectus for the offer of 21,000,000 fully paid ordinary shares to the public at an Offer Price of $1.00 per share to raise up to $21,000,000. The Company has entered into an agreement for the acquisition of 100% of the issued capital of Advent Health. AHPL has in turn entered into agreements to acquire a number of multi-disciplinary allied health practices. The Acquisitions will involve a significant change in the nature and scale of the Company's activities, which requires the approval of Shareholders under Chapter 11 of the ASX Listing Rules.

16/03/2020

The company lodges its Half Yearly Report and Accounts.

27/02/2020

The company lodges its Appendix 4C - quarterly.

24/01/2020

The company releases the results of its meeting.

29/11/2019

The company releases the Chairman's Address to Shareholders.

29/11/2019

The company's AGM will be held at 9U, 175 Lower Gibbes Street, Chatswood NSW 2067 at 11:00 am Sydney time on Friday 29 November 2019.

30/10/2019

The company lodges its Appendix 4C - quarterly.

18/10/2019

The company releases its Appendix 4G Corporate Governance Disclosure.

28/08/2019

The company lodges its Annual Report to shareholders.

28/08/2019

The company lodges an Appendix 4C - quarterly.

23/07/2019

The company lodges an Appendix 4C - quarterly.

23/04/2019

The company lodges its Half Yearly Report and Accounts.

27/02/2019

The company lodges an Appendix 4D.

27/02/2019

The company issues a response to ASX Query regarding its Appendix 4C.

20/02/2019

The company will repay the A$1.5 million of Convertible Notes currently on issue. An agreement between the Company and the Notes Holder has been signed for MHD to redeem all Notes that are outstanding on 12 February 2019. MHD will now redeem all Convertible Notes at the price of A$1.00 per Note (total A$1,500,000) and any interest accrued up to the Early Redemption Date (total A$193,438) as per the terms of the Convertible Notes Deed. The Early Redemption will save the Company approximately $186,000 in future interest payments.

13/02/2019

Settlement of 47 Brookes Street Bowen Hills Property occurred on 31 January 2019.

01/02/2019

The company lodges its Appendix 4C - quarterly.

22/01/2019

The company releases the Results of Meeting.

08/11/2018

The company releases the Chairman's Address to Shareholders.

08/11/2018

The company lodges its Appendix 4C - quarterly.

22/10/2018

The company releases a notice of AGM and proxy form. The Annual General Meeting of the Shareholders of Millennium Limited will be held at Unit 9U, 175 Lower Gibbes Street, Chatswood, NSW 2067, Australia, on Thursday, 8 November 2018 at 11:00 am.

05/10/2018

The company releases its Appendix 4G Corporate Governance Disclosure.

31/08/2018

The company lodges its Annual Report to shareholders.

31/08/2018

The securities of Millennium Limited will be suspended from quotation immediately in accordance with Listing Rule 17.3, as ASX has determined that the Company's operations are not adequate to warrant the continued quotation of its securities and therefore it is in breach of Listing Rule 12.1. The suspension will continue until the Company is able to demonstrate compliance with Listing Rule 12.1 of the Listing Rules.

13/08/2018

name changed from Yanghao International Limited

31/08/2017

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

can you cristilize my losses in millenium 440000 shares

21/09/2020 14:40:08

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Wei HuangNon Exec Director28/11/2008
    Bryce WedemeyerNon Exec Director13/03/2020
    Cris MassisExecutive Director13/03/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Yan YangExecutive Chairman21/05/201413/03/2020
    Ying HuangNon Exec Director26/11/201513/03/2020
    Jiang SongExecutive Director07/09/201513/03/2020
    Cathy GuoIndependent Director19/04/201126/11/2015
    Jie YangAlternate Director27/08/201007/09/2015
    Xuefu YangExecutive Director05/05/201021/04/2014
    Jack HuangNon Exec Director13/10/200805/07/2011

    Date of first appointment, title may have changed.